首页>
外国专利>
Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples
Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples
展开▼
机译:使用患者样品的质谱监测通过药物EGFR途径监测头颈癌患者的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods using mass spectral data analysis and a classification algorithm provide an ability to determine whether a non-small-cell lung cancer patient, head and neck squamous cell carcinoma or colorectal cancer patient has likely developed a non-responsiveness to treatment with a drug targeting an epidermal growth factor receptor pathway. As the methods of this disclosure require only simple blood samples, the methods enable a fast and non-intrusive way of measuring when drugs targeting the EGFR pathway cease to be effective in certain patients. This discovery represents the first known example of true personalized selection of these types of cancer patients for treatment using these classes of drugs not only initially, but during the course of treatment.
展开▼